Scientists target Hep C virus using CRISPR-Cas technology
Scientists in the US have used the CRISPR-Cas system to target the RNA of hepatitis C virus (HCV).
Scientists in the US have used the CRISPR-Cas system to target the RNA of hepatitis C virus (HCV).
BASF has hiked up the price of ethanolamines in Europe citing increased cost of raw materials and continuous demand.
Indian CRO Syngene has reported a record quarter as it gets set to spin-out from its parent company Biocon.
Persuading API manufacturers to seek prequalification is a challenge according to the WHO, which wants to raise awarness about the process and the positive impact it has on a suppliers' reputation.
Inaccurate and incomplete information on excipients referenced in the US FDA Inactive Ingredient Database (IID), as well as other agency policies and guidance on the review of inactive ingredients in ANDAs (Abbreviated New Drug Applications) “continue to...